The treatment, extending Alfie's leg by installing a lengthening nail on the surface of his thigh bone, started in March last ...

Please provide your email address to receive an email when new articles are posted on . In patients with diabetes and major adverse limb events, GLP-1s conferred better outcomes than DPP-IV inhibitors ...

People with diabetes and a history of major adverse limb events face a markedly increased risk of future amputations, cardiovascular disease, and kidney failure. Until now, evidence to guide glucose ...

Dr. James C. Wittig, one of the world's top orthopedic oncologists, led a team of residents and innovators in 2024 to successfully implement a surgical solution for an exceedingly rare orthopedic ...

A 43-year-old woman presented with insidious onset of neurocognitive decline, alien limb phenomenon, and personality changes. A case report by Anza Zahid, MD, a neurology resident at the Stanley H.

Another person treated with a Sarepta Therapeutics gene therapy has died, compounding concerns about the safety of the company’s genetic treatments. Sarepta on Friday confirmed the death of a ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

WICHITA, Kan. (KAKE) - A firefighter, a medic and a patient were all injured Sunday evening when a large tree branch unexpectedly fell during a rescue operation, according to the Wichita Fire ...

Please provide your email address to receive an email when new articles are posted on . GLP-1s were linked to reduced risk for major adverse CV and limb events at 1 year in patients with moderate ...